Michel Sadelain
0000-0002-9031-8025
7 papers found
Refreshing results…
Prophylactic and long-lasting efficacy of senolytic CAR T cells against age-related metabolic dysfunction
Novel extragenic genomic safe harbors for precise therapeutic T cell engineering
Generation of T-cell-receptor-negative CD8αβ-positive CAR T cells from T-cell-derived induced pluripotent stem cells
HLA-independent T cell receptors for targeting tumors with low antigen density
Interventions and outcomes of adult patients with B-ALL progressing after CD19 chimeric antigen receptor T-cell therapy
Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL
The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells
Missing publications? Search for publications with a matching author name.